Back to MA Mather Group, LLC

MRNA

16 quarters

Position history for MAMather Group, LLC's holdings in Moderna, Inc.

Yes. Mather Group holds 7,756 shares of MRNA (Moderna), worth $1.5M, as of its Q3 2026 13F filing. It increased the position by 152 shares (+2.0%) from Q2 2026. Mather Group has held MRNA since Q1 2024, across 11 quarterly 13F filings.

Current Value

$1.5M

Current Shares

7,756

Total Value Change

+$478,573

Total Shares Change

+1,861

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
7,756
+2.0%
$1.5M0.0%$192.57
26
2026-Q2
Decreased
7,604
-0.5%
$532,5080.0%$70.03
0
2026-Q1
Increased
7,645
+7.8%
$388,3660.0%$50.80
26
2025-Q4
Decreased
7,094
-32.4%
$209,2020.0%$29.49
0
2025-Q3
Decreased
10,496
-3.8%
$271,1120.0%$25.83
0
2025-Q2
Increased
10,914
+181.4%
$301,1170.0%$27.59
38
2025-Q1
Increased
3,879
+472.1%
$109,9740.0%$28.35
35
2024-Q4
Decreased
678
-47.1%
$28,1910.0%$41.58
0
2024-Q3
Increased
1,281
+25.7%
$85,6090.0%$65.75
26
2024-Q2
Increased
1,019
+76.9%
$108,5850.0%$118.75
33
2024-Q1
New
576
-
$57,2840.0%$106.56
29
2023-Q1
Exited
0
-100.0%
$00.0%$147.44
0
2022-Q4
Decreased
6,599
-8.3%
$1.2M0.0%$179.62
0
2022-Q3
Decreased
7,200
-6.9%
$851,0000.0%$118.07
0
2022-Q2
Increased
7,731
+31.1%
$1.1M0.0%$142.81
32
2022-Q1
New
5,895
-
$1M0.0%$174.92
35

Other major holders of MRNA: Baillie Gifford & Co.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used